Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The GMC Life Sciences Fund is a £20 million investment vehicle launched by the Greater Manchester Combined Authority (GMCA) in partnership with Cheshire and Warrington LEP and Bruntwood SciTech. Managed by Praetura Ventures, the fund is dedicated to supporting early-stage and growing life sciences businesses across the Greater Manchester, Cheshire, and Warrington regions. It targets companies specializing in diagnostics, therapeutics, and digital health, aiming to foster innovation and economic growth within the UK's North West life sciences cluster. The fund provides not only capital but also strategic support and access to a broad network of industry experts and infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GMC Life Sciences Fund.